Unlike the heart or lungs, the brain resists generalization: regions governing language, vision, and movement sit in different places in every person, making neurosurgery delicate, since crossing into functional tissue can cause lasting harm. Neurotech company BrainSight AI, led by co-founder and CTO Dr. Rimjhim Agarwal, addresses this by fusing structural, functional, and diffusion MRI scans into one patient-specific functional map, aiming to show surgeons not just where a tumor sits but which neural pathways run through it, much like layering roads, routes, and live traffic onto one map.
This work depends on handling brain data responsibly, since it reveals personal information about how a person thinks. Dassault Systèmes India stresses that data protection, consent, and compliance must be designed into such platforms from the start, not added later. Dr. Agarwal separately views India’s diverse population as a scientific advantage, since it helps AI models generalize more reliably worldwide.
This variability now shapes treatment too. On Dassault Systèmes’ 3DEXPERIENCE platform, “virtual brain twins,” digital models built from a patient’s own scans, aim to let doctors test a therapy, such as non-invasive brain stimulation, before actual use.
Together, these efforts point toward brain care shifting from broad treatment to a more personalized, simulation-first approach.
Image courtesy: Dassault Systèmes
